Johnson & Johnson SEC filings JNJ
Johnson & Johnson has 1,000 filings in SEC EDGAR's recent list, going back to Aug 2, 2018. Its latest annual report, Form ARS, was filed on Mar 11, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 21, 2026 | Sep 27, 2026 |
| 10-Q | Quarterly report | Jul 23, 2026 | Jun 28, 2026 |
| 10-Q | Quarterly report | Apr 22, 2026 | Mar 29, 2026 |
| 10-Q | Quarterly report | Oct 22, 2025 | Sep 28, 2025 |
| 10-Q | Quarterly report | Jul 24, 2025 | Jun 29, 2025 |
| 10-Q | Quarterly report | Apr 23, 2025 | Mar 30, 2025 |
| 10-Q | Quarterly report | Oct 23, 2024 | Sep 29, 2024 |
| 10-Q | Quarterly report | Jul 25, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Oct 27, 2023 | Oct 1, 2023 |
| 10-Q | Quarterly report | Jul 31, 2023 | Jul 2, 2023 |
| 10-Q | Quarterly report | Apr 28, 2023 | Apr 2, 2023 |
| 10-Q | Quarterly report | Oct 27, 2022 | Oct 2, 2022 |
| 10-Q | Quarterly report | Jul 29, 2022 | Jul 3, 2022 |
| 10-Q | Quarterly report | Apr 29, 2022 | Apr 3, 2022 |
| 10-Q | Quarterly report | Oct 29, 2021 | Oct 3, 2021 |
| 10-Q | Quarterly report | Jul 29, 2021 | Jul 4, 2021 |
| 10-Q | Quarterly report | Apr 30, 2021 | Apr 4, 2021 |
| 10-Q | Quarterly report | Oct 23, 2020 | Sep 27, 2020 |
| 10-Q | Quarterly report | Jul 24, 2020 | Jun 28, 2020 |
| 10-Q | Quarterly report | Apr 29, 2020 | Mar 29, 2020 |
| 10-Q | Quarterly report | Oct 28, 2019 | Sep 29, 2019 |
| 10-Q | Quarterly report | Jul 29, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 1, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Oct 31, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 2, 2018 | Jul 1, 2018 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JNJ (NYSE)
- Fiscal year ends
- January 3
- Incorporated in
- NJ
- Headquarters
- New Brunswick, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 200406
- Former names
- JOHNSON & JOHNSON ET AL (until Jan 23, 1996)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.